Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5514646 | LILLY | Insulin analogs modified at position 29 of the B chain |
May, 2013
(11 years ago) | |
US5461031 | LILLY | Monomeric insulin analog formulations |
Jun, 2014
(9 years ago) | |
US5474978 | LILLY | Insulin analog formulations |
Jun, 2014
(9 years ago) | |
US5747642 | LILLY | Monomeric insulin analog formulations |
Jun, 2014
(9 years ago) |
Humalog Mix 50/50 is owned by Lilly.
Humalog Mix 50/50 contains Insulin Lispro Protamine Recombinant; Insulin Lispro Recombinant.
Humalog Mix 50/50 has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Humalog Mix 50/50 are:
Humalog Mix 50/50 was authorised for market use on 22 December, 1999.
Humalog Mix 50/50 is available in injectable;injection dosage forms.
Humalog Mix 50/50 can be used as use for the treatment of hyperglycemia, treatment of diabetes mellitus.
The generics of Humalog Mix 50/50 are possible to be released after 16 June, 2014.
Market Authorisation Date: 22 December, 1999
Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus
Dosage: INJECTABLE;INJECTION